Anavex Life Sciences Corp. (AVXL.OB) Invited to File Funding Application for Phase 2a Clinical Trial of ANAVEX 2-73
5/6/2013 10:17:21 AM
More...
|
Anavex Life Sciences Corp. (AVXL.OB) Comments on FDA Plan to Expedite Approval of New Alzheimer's Drugs
3/18/2013 12:22:57 PM
More...
|
Anavex Life Sciences Corp. (AVXL.OB) Comments on FDA Plan to Expedite Approval of New Alzheimer's Drugs
3/18/2013 10:34:14 AM
More...
|
Anavex Life Sciences Corp. (AVXL.OB) Release: ANAVEX 2-73 Restores Mitochondrial Functionality, Blocks Cell Death and Oxidative Stress, Preventing Onset of Alzheimer's Disease
3/12/2013 10:36:42 AM
More...
|
Anavex Life Sciences Corp. (AVXL.OB) Retains Novak Druce Connolly Bove & Quigg to Maximize Value of Intellectual Property Portfolio
2/4/2013 10:35:19 AM
More...
|
Anavex Life Sciences Corp. (AVXL.OB) Appoints Tom Skarpelos as Director
1/10/2013 11:43:26 AM
More...
|
Anavex Life Sciences Corp. (AVXL.OB) Release: ANAVEX 2-73 Shown to Block Oxidative Stress, Preventing Onset of Alzheimer's Disease
10/18/2012 11:11:38 AM
More...
|
Anavex Life Sciences Corp. (AVXL.OB) to Present at NeuroScience 2012 in New Orleans
10/15/2012 10:28:17 AM
More...
|
Anavex Life Sciences Corp. (AVXL.OB) Recognizes Alzheimer's Action Day
9/21/2012 11:53:48 AM
More...
|
Anavex Life Sciences Corp. (AVXL.OB) Presents Compelling Data at World's Largest Alzheimer's Conference
7/17/2012 10:06:44 AM
More...
|
|